review | multiple sclerosis

Multiple sclerosis is a field that has really exploded in the last ten years, with a myriad of new immunologically based therapies being used. These include alemtuzumab, daclizumab, and various other antibodies – if these don’t sound familiar or you’re just interested in this area, then have a look at this new Rapid Review in The Lancet Neurology.

source | The Lancet Neurology

image | KOMUnews

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s